Indegene Intrinsic Value
INDGN • Healthcare
Current Stock Price
₹464.65
Primary Intrinsic Value
₹374.88
Market Cap
₹2230 Cr
+100.0%
Upside
Median Value
₹929.30
Value Range
₹139 - ₹1162
Assessment
Trading Below Calculated Value
Safety Margin
50.0%
INDGN Valuation Methods Summary
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹374.88 | ₹299.90 - ₹449.86 | -19.3% | EPS: ₹17.04, Sector P/E: 22x |
| Book Value Method | asset | ₹1090.00 | ₹981.00 - ₹1199.00 | +134.6% | Book Value/Share: ₹545.00, P/B: 2.0x |
| Revenue Multiple Method | revenue | ₹929.30 | ₹836.37 - ₹1022.23 | +100.0% | Revenue/Share: ₹686.67, P/S: 2.0x |
| EBITDA Multiple Method | earnings | ₹929.30 | ₹836.37 - ₹1022.23 | +100.0% | EBITDA: ₹640.00Cr, EV/EBITDA: 10x |
| Simple DCF (5Y) | dcf | ₹1161.62 | ₹929.30 - ₹1393.94 | +150.0% | CF Growth: 15.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹139.39 | ₹125.45 - ₹153.33 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹263.27 | ₹236.94 - ₹289.60 | -43.3% | Revenue Growth: 6.0%, Adj P/E: 15.5x |
| ROE Based Valuation | profitability | ₹929.30 | ₹836.37 - ₹1022.23 | +100.0% | ROE: 15.6%, P/E Multiple: 14x |
| Graham Defensive Method | conservative | ₹457.11 | ₹411.40 - ₹502.82 | -1.6% | EPS: ₹17.04, BVPS: ₹545.00 |
Method Types:
Earnings
Asset
DCF
Growth
Dividend
Conservative
Valuation Comparison Chart
INDGN Intrinsic Value Analysis
What is the intrinsic value of INDGN?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Indegene (INDGN) is ₹929.30 (median value). With the current market price of ₹464.65, this represents a +100.0% variance from our estimated fair value.
The valuation range spans from ₹139.39 to ₹1161.62, indicating ₹139.39 - ₹1161.62.
Is INDGN undervalued or overvalued?
Based on our multi-method analysis, Indegene (INDGN) appears to be trading below calculated value by approximately 100.0%.
Financial Health Analysis
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 17.33 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 15.6% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | 17.0% | Industry Standard: 20%+ | Above 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.99x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
Related Pages for Indegene
Additional stock information and data for INDGN
Cash Flow Quality Analysis
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹442 Cr | ₹104 Cr | Positive Free Cash Flow | 7/10 |
| March 2024 | ₹508 Cr | ₹345 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹130 Cr | ₹-318 Cr | Positive Operating Cash Flow | 6/10 |
| March 2022 | ₹297 Cr | ₹218 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹172 Cr | ₹132 Cr | Positive Free Cash Flow | 8/10 |